Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000162

EVP & Chief Financial Officer sold 3,250 shares at $454.79 ($1,478,068)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WAGNER CHARLES F JR · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-28 Sale : show line 1 in the form 10b5-1 −3,250 $454.79 $1,478,068 50,387 D
Open-market sales · 3,250 sh · avg $454.79 · $1,478,068
Loading xslF345X05/wk-form4_1717099663.xml…